Related Experiment Videos

[Changes induced by venous occlusion in coagulation and fibrinolysis in patients with old myocardial infarction]

T Suzuki1, K Yamauchi, Y Yamada

  • 1First Department of Internal Medicine, Nagoya University School of Medicine.

Kokyu to Junkan. Respiration & Circulation
|January 1, 1991
PubMed

Insights

Patients with myocardial infarction exhibit hypercoagulability and hypofibrinolysis, particularly those with diabetes. Impaired vascular endothelial function is linked to elevated PAI-1 and alpha 2 PI levels, affecting tissue plasminogen activator (t-PA) activity.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Endocrinology

Context:

  • Assessing vascular endothelial function in patients post-myocardial infarction (MI) is crucial for understanding thrombotic risk.
  • Previous research indicates altered hemostatic and fibrinolytic profiles in cardiovascular disease patients.

Purpose:

  • To evaluate vascular endothelial function by measuring hemostatic and fibrinolytic parameters before and after venous occlusion in MI patients and healthy controls.
  • To identify specific markers associated with hypercoagulability and hypofibrinolysis in MI patients, especially those with comorbid diabetes mellitus.

Summary:

  • Venous occlusion revealed significantly lower tissue plasminogen activator (t-PA) activity post-occlusion in MI patients compared to controls, most pronounced in those with diabetes.
  • Elevated plasminogen activator inhibitor-1 (PAI-1) and alpha 2-plasmin inhibitor (alpha 2 PI) levels were observed in MI patients, contributing to reduced t-PA activity.
  • Pre-occlusion levels of t-PA antigen and Factor VIII related antigen (VIII R: Ag) were higher in MI patients, but release upon occlusion was similar to controls, suggesting a baseline hypercoagulable and hypofibrinolytic state.

Impact:

  • Findings suggest that MI patients, particularly those with diabetes, are in a prothrombotic state characterized by impaired fibrinolysis.
  • The study highlights the role of PAI-1 and alpha 2 PI in modulating t-PA activity and endothelial function in this patient population.
  • These insights can inform the development of targeted therapeutic strategies to mitigate thrombotic events in post-MI patients.

Related Concept Videos